1. Substituted indole-1-acetic acids as potent and selective CRTh2 antagonists—discovery of AZD1981
- Author
-
Hitesh J. Sanganee, Iain G. Dougall, Jerzy Schmidt, Tim Luker, Roger Bonnert, Carol Sargent, Stephen Thom, Chris Logan, Rukhsana Tasneem Mohammed, Stuart W. Paine, Steve Brough, Simon J. Teague, Anthony Ronald Cook, and Dickinson Mark
- Subjects
Indole test ,Aldose reductase ,Indoles ,Indoleacetic Acids ,Neutrophils ,Chemistry ,Receptors, Prostaglandin ,Organic Chemistry ,Clinical Biochemistry ,Pharmaceutical Science ,Chemotaxis ,Metabolism ,Acetates ,Pharmacology ,Biochemistry ,Aldehyde reductase activity ,In vivo ,Drug Discovery ,Humans ,Molecular Medicine ,Potency ,Receptors, Immunologic ,Receptor ,Molecular Biology - Abstract
Novel indole-3-thio-, 3-sulfonyl- and 3-oxy-aryl-1-acetic acids are reported which are potent, selective antagonists of the chemoattractant receptor-homologous expressed on Th2 lymphocytes receptor (CRTh2 or DP2). Optimization required maintenance of high CRTh2 potency whilst achieving a concomitant reduction in rates of metabolism, removal of cyp p450 inhibition and minimization of aldose reductase and aldehyde reductase activity. High quality compounds suitable for in vivo studies are highlighted, culminating in the discovery of AZD1981 (22).
- Published
- 2011
- Full Text
- View/download PDF